008930 — Hanmi Science Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩2tn
- KR₩2tn
- KR₩1tn
- 63
- 24
- 16
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 16,747 | 14,849 | 16,591 | 21,421 | 33,579 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 91,092 | 87,903 | 94,216 | 110,550 | 108,771 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 217,079 | 215,727 | 222,559 | 245,348 | 273,900 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 26,341 | 25,641 | 26,044 | 88,919 | 94,068 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 910,832 | 923,220 | 949,894 | 1,109,691 | 1,226,170 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 228,188 | 220,113 | 220,995 | 347,726 | 395,202 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 265,147 | 264,484 | 259,596 | 384,945 | 438,663 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 645,686 | 658,736 | 690,298 | 724,746 | 787,507 |
Total Liabilities & Shareholders' Equity | 910,832 | 923,220 | 949,894 | 1,109,691 | 1,226,170 |
Total Common Shares Outstanding |